Over 50% Russian doctors have no trust in hastily developed coronavirus vaccine

International
Typography

The doctors have expressed their opinion on the vaccine in an online survey involving more than 3,000 healthcare professionals. It found that more than half of them are not ready to get the vaccine.

More than 50 percent doctors in Russia have expressed lack of trust in the world’s first registered vaccine against coronavirus.

An online survey involving more than 3,000 healthcare professionals found that more than half of them are not ready to get the vaccine, according to a report in Times Now.

The vaccine, Sputnik V, developed jointly by Gamaleya Research Institute and the Russian Defence Ministry is set to be rolled out by the end of August. Announcing the launch of the vaccine, President Vladimir Putin said that Sputnik V inoculation gave ‘sustainable immunity’ to volunteers, including one of his daughters.

However, the report, citing an online survey obtained by the RBC news website, stated that about one in two Russian medics - 52 per cent - surveyed by the Doctor’s Handbook app said that they won’t take the Sputnik V vaccine, formally named ‘Gam-COVID-Vak.

According to RBC, the online survey found that only 24 per cent of healthcare workers are willing to get vaccinated against COVID-19. The survey found that out of the 52 per cent Russian medics who said they won’t get the new vaccine, 66 per cent cited insufficient data proving its effectiveness, whereas 48 per cent said it was developed too quickly.

The survey found that 20 per cent of medics who said they won’t get vaccinated reported that they’d still recommend Sputnik V to patients, colleagues and friends.

“It’s normal for trust to be earned through years of application. But one shouldn’t confuse trust with the official assessment of safety and efficiency. These results allow experts to conclude that the vaccine can be used,” Deputy Health Minister Oleg Salagay wrote on Telegram in response to the survey, adding that the results are par for the course.

News agency Tass reported that several tens of thousands of people are expected to take part in the third stage of the vaccine which may begin in 7-10 days. Moscow claimed that the Sputnik V vaccine can confer up to two years of immunity to COVID-19.

Close on the heels of the Russian launch, China accelerated work on a novel COVID-19 produced by one of its local companies, biopharmaceutical firm CanSino Biologics recently. According to the latest reports, Chinese authorities granted the patent after studies proved that the vaccine prototype concurred with creative and intellectual property bases set by Beijing officials.

The issual of a patent makes CanSino's vaccine the first one to be approved by China. A statement published in People's Daily, the patent was granted on August 11, around the same date Russia registered its coronavirus vaccine, Sputnik V, according to a Times of India report.

The Chinese vaccine titled, Ad5-nCOV, which was first submitted for approvals in the month of March makes use of a version of a common cold virus strain to transport genetic material into the human body and train it to prevent further infection and spike up antibodies in the host body.

Early studies have suggested that the experimental vaccine, which is amongst the 5 vaccines being locally made and developed in China is one of the safest vaccines right now. Scientists were able to observe positive immunity and increased T-cell production levels in the body post phase I and II trials.

Cansino Biologics's novel vaccine was, interestingly, also granted emergency authorization to be used by Chinese military officials in late June. Work on the vaccine has also been speedily done, with experts now hopeful of conducting phase III in a much more broader scale.

Image Credit: DNA India  

All Comments